From Glucose Control to Whole-Person Care - New Hope for Diabetes
There's genuine reason for optimism in diabetes care.
This Diabetes Awareness Month, discover how treating the whole person, including biology, psychology, and social context, is bringing new hope to millions living with diabetes. From GLP-1 innovations to behavioral support systems, the future embraces diabetes in all its complexity.
The lesson? As we uncover the true complexity of diabetes - in the disease itself, its treatment, and patients' lived experiences - we unlock better outcomes. This deeper understanding benefits not just diabetes, but all chronic conditions.
Complete the form to access personal perspectives on diabetes care today from BGB Group’s Angelo Casa, Ph.D.
About the author: Angelo Casa, Ph.D. - AVP, Medical Director, Medical Strategy and Scientific Affairs at BGB Group - With a Ph.D in Molecular and Cellular Biology from Baylor College of Medicine, nine years of medical communications expertise at BGB Group, and prior experience as lead scientist at Weill Cornell Medicine, Angelo brings unique bench-to-business perspectives to diabetes care discussions.
About BGB Group: BGB Group, founded in 2005, is an independent agency with more than 500 employees that provides comprehensive services spanning healthcare advertising, medical communications, payer and market access, and strategic consulting for pharmaceutical, biotechnology, and medical technology organizations. BGB delivers innovative solutions across diverse therapeutic areas, and is committed to speed, efficiency, and superior results that drive impactful outcomes for its clients. Learn more at www.bgbgroup.com.
There's genuine reason for optimism in diabetes care.
This Diabetes Awareness Month, discover how treating the whole person, including biology, psychology, and social context, is bringing new hope to millions living with diabetes. From GLP-1 innovations to behavioral support systems, the future embraces diabetes in all its complexity.
The lesson? As we uncover the true complexity of diabetes - in the disease itself, its treatment, and patients' lived experiences - we unlock better outcomes. This deeper understanding benefits not just diabetes, but all chronic conditions.
Complete the form to access personal perspectives on diabetes care today from BGB Group’s Angelo Casa, Ph.D.
About the author: Angelo Casa, Ph.D. - AVP, Medical Director, Medical Strategy and Scientific Affairs at BGB Group - With a Ph.D in Molecular and Cellular Biology from Baylor College of Medicine, nine years of medical communications expertise at BGB Group, and prior experience as lead scientist at Weill Cornell Medicine, Angelo brings unique bench-to-business perspectives to diabetes care discussions.
About BGB Group: BGB Group, founded in 2005, is an independent agency with more than 500 employees that provides comprehensive services spanning healthcare advertising, medical communications, payer and market access, and strategic consulting for pharmaceutical, biotechnology, and medical technology organizations. BGB delivers innovative solutions across diverse therapeutic areas, and is committed to speed, efficiency, and superior results that drive impactful outcomes for its clients. Learn more at www.bgbgroup.com.
Need expert guidance navigating the complexities of modern diabetes care?
Our medical, strategy, and creative teams are here to help. Contact Amanda Eckel at aeckel@outreach.bgbgroup.com to discuss your diabetes communications goals.
Copyright © 2025 BGB Group. All rights reserved.